LINDSEY VOLLONO: Open Payments
NPI 1477836286 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 51 payments from 27 companies in 2025. Trend: 2023 $1,991 · 2024 $2,979 · 2025 $2,129
Long term medical supply or device loan: $1,147Food & beverage: $981
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $1,205 |
| Kite Pharma, Inc. | 1 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| BeOne Medicines USA, Inc. | 2 | $56 |
| Gilead Sciences, Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| JAZZ PHARMACEUTICALS INC. | 2 | $45 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ABBVIE INC. | 1 | $34 |
Products named: KISQALI, Yescarta, SCEMBLIX, Trodelvy, CALQUENCE, ZEPZELCA, DANZITEN, OPDIVO.
Industry payments across SC — which companies pay providers there.
